GHRH Analog
Also known as Growth-Hormone-Releasing Hormone Analog
A class of peptides that mimic growth-hormone-releasing hormone at the pituitary to trigger the body's own GH release — CJC-1295, Tesamorelin and Sermorelin.
Definition
GHRH analogs bind the GHRH receptor on pituitary somatotrophs and stimulate endogenous growth-hormone release. Because they work upstream of the pituitary, they preserve the body's negative-feedback loop — unlike exogenous HGH, which shuts that loop down. Sermorelin is the native sequence; CJC-1295 is a modified analog; Tesamorelin is the pharmaceutical-grade stabilised variant with the strongest RCT evidence.
Read More
CJC-1295CJC-1295 no-DAC
A GHRH analog that extends the body's natural growth-hormone pulses — typically paired with Ipamorelin for muscle preservation and sleep quality.
PeptideTesamorelin
A stabilised GHRH analog with FDA approval for visceral-fat reduction in HIV-associated lipodystrophy — increasingly used off-label for metabolic syndrome.
PeptideSermorelin
A native GHRH analog — the gentlest and most-studied entry point into growth-hormone-axis therapy.
$149 panel.
A clinician reads it in 24 hours.
Order the Peptide Readiness Panel, draw at a Quest or LabCorp near you, and your clinician sends back a matched protocol with a confidence score.